期刊文献+

人巨噬细胞移动抑制因子水平与结核病易感性关系

Relationship between human serum MIF level and TB susceptibility
原文传递
导出
摘要 目的通过研究结核病人和正常人体内巨噬细胞移动抑制因子(Migration inhibitory factor,MIF)表达水平,分析MIF与结核病易感性关系。方法选取昆明市第三人民医院结核病患者41例(16名男性,25名女性),及昆明市疾控中心健康体检者41例(20名男性,21名女性),采用酶联免疫吸附法(ELISA)检测血清中的MIF水平。结果结核病组MIF水平(43.24±29.29)明显高于正常对照组(20.86±11.99),(P<0.01)。结论 MIF在人感染结核病中发挥重要免疫作用。 Aim To analyze the relationship between human serum MIF level and TB susceptibility through investigating expressin level of tuberculosis and normal body maerophage migration inhibitory factor (MIF). Methods There 4t tuberculosis cases were selected kom Kunming Municipal Third People's Hospital (16males arid 25 females) and another 41 normal persons attending Kunming Municipal Center for Disease Control and Prevention for health check-up (20males and 21females),The expression level of human serum MIF was determined using the enzyme-linked immunosorbent adsorption method(ELISA). Results The MIF level in TB gwup(43.24±29.29) was significantly higher than that of the conu'ol group (20.86±11.99), (P〈0.01). Conclution MIF may play an important role in immune responses to human infection with Mycobacterium tuberculosis.
出处 《中国热带医学》 CAS 2011年第7期783-784,共2页 China Tropical Medicine
基金 云南省应用基础研究项目(No.2010CD221) 云南省教育厅科学研究基金(No.08Y0240)
关键词 巨噬细胞移动抑制因子 结核病 酶联免疫吸附法 Macrophage migration inhibitory factor Tuberculosis Enzyme-linked immunosorbent adsorption
  • 相关文献

参考文献17

  • 1端木宏谨.21世纪结核病控制与研究工作展望[J].中华结核和呼吸杂志,2000,23(1):6-8. 被引量:85
  • 2Bellamy R. Susceptibility to ycobaeterial infections:the importance of host genetics[J]. Genes and Immunity, 2003,4( 1 ) :4-11.
  • 3Alcais A,Fieschi C ,Abel L,et al. Tuberculosis in children and adults: two distinct generic diseases [J] . J Exp Med,2005,202(12) : 1617- 1621.
  • 4Alcais A,Abel L,Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm [J] . J Clin Invest,2009, 119(9) :2506-2514.
  • 5Casanova JL,Abel L. Human genetics of infectious diseases:a unified theory [J]. J EMBO J,2007,26(4):915-922.
  • 6PAN JH, LINDHOLT JS, SUKHOVA GK, et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion [J]. J Vase Surg, 2003,37 ( 3 ) : 628-635.
  • 7HERDER C,KOLR H,KOEING W,et al . Association" of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes:results from the Cooperative Health Research in the Region of Augsburg,Survey 4 (KORA S4)[J]. Diabetes Care,2006,29 (2):368-371.
  • 8Yamada G,Shijubo. N,Takagi-Takahashi. Y,et al. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis[J]. Clinical Immunology,2002,104:123-127.
  • 9MartinezA, Orozco G, Varade J, et al. Macroph agemigration inhibitory factor gene:influcnce on rheumatoid arthritis susceptibillty[J]. Human hnmunology, 1,2007,68 (9) : 744-747.
  • 10Renner P, Roger T, Calandra T, et al. Maeroph agemigration inhibitory factor(MIF):gene polymorphisms and susceptibility to inflammatory diseases [J] . Clinical infectious diseases,2005,41($7):513-519.

二级参考文献23

  • 1Alcais A, Fieschi C, Abel L, et al. Tuberculosis in children and adults: two distinct generic diseases [J]. J Exp Med, 2005,202(12) : 1617-1621.
  • 2Alcais A, Abel L, Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm [J]. J Clin Invest, 2009,119(9):2506-2514.
  • 3Casanova JL, Abel L. Human genetics of infectious diseases: a unified theory [J]. EMBO J, 2007,26(4):915-922.
  • 4Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis [J~. Nature Reviews Drug Discov, 2005,5 : 399-411.
  • 5Calandra T, Buca|a R. Macrophage migration inhibitory factor (MIF) : aglucocorticoid counter-regulator within the immune system [J]. Crit Rev Immunol, 1997,17(1) :77-88.
  • 6van Crevel R, Ottenhoff THM, van der Meet WM. Innate immunity to Mycobacterium tuberculosis [J~. Clin Mierobiol Rev, 2002,15(2) :294-309.
  • 7North RJ, Jung YJ. Immunity to tuberculosis [J]. Annu Rev Immunol, 2004,22 : 599-623.
  • 8Bloona BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity [J]. Science, 1966,153 (731) : 80-82.
  • 9David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction [J]. Proc Natl Acad Sci USA, 1966,56(1):72-77.
  • 10Lue H, Kleemann R, Calandra T, et al. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease [J]. Micr Infect, 2002,4(4) :449-460.

共引文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部